Emerging Growth Companies
Since our founding in 1970, we have served the needs of start-up and emerging-growth companies, including in the technology and life sciences industries. Our corporate attorneys understand the special financing and other business needs of new business ventures and their investors. We stay abreast of the newest trends among start-ups, including the advent of ICOs and blockchain technology.
We also have long-standing relationships with the funding sources for start-up and emerging growth ventures, including crowd funding, angel investors, seed investors, incubators and venture capital firms. In addition, we understand, and regularly advise our clients on, the key role that intellectual property plays at these companies.
Representative matters we have handled include the following:
- Represented start-up electronic medical records company in “friends and family” rounds of financing and sale of majority interest to venture capital fund.
- Represented start-up veterinary medicine biopharmaceutical company in seed funding by co-founder and institutional and high net-worth individual investors and in preparation for the company’s $60.375 million initial public offering within 15 months of start-up.
- Represented start-up record label in formation as a limited liability company and in private financing.
- Represented multiple issuers in technology and other growth industries in preferred equity and convertible debt offerings to venture capital funds, private investor groups, and angel investors.
- Represented PE funds, private investor groups, and angel investors in multiple preferred equity and convertible debt investments.
- Represented entrepreneur-chef of start-up multi-location restaurant group.
- Represented secured promissory note holders in UCC foreclosures on software companies and asset sales to PE funds.
- Represented PE funds in formation as limited partnerships or limited liability companies and in conflict-of-interest and governance issues.
- Represented companies in industries ranging from manufacturing to technology-based services in day-to-day operations, including sales, distribution, licensing, services, and manufacturing agreements.
- First ICO Registration Statement Filed with the SEC Raises More Questions Than Answers
- November 2015: SEC Adopts Rules to Permit Crowdfunding; Proposes Amendments to Existing Rules to Facilitate Capital Raising by Smaller Companies
- January 2014: Small Public Offerings – New Regulation A+ Rules Issued by SEC
- TroyGould Represents Lixte Biotechnology Holdings, Inc. in Public Offering of Common Stock and Warrants